FMR LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 75 filers reported holding BRIDGEBIO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
FMR LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$61,041,405
+113.7%
2,427,522
+46.2%
0.01%
+150.0%
Q2 2023$28,567,187
-59.1%
1,660,883
-60.5%
0.00%
-33.3%
Q1 2023$69,776,412
+1202.4%
4,208,468
+498.6%
0.00%
+200.0%
Q4 2022$5,357,664
-45.2%
703,105
-28.5%
0.00%0.0%
Q3 2022$9,774,000
+9.8%
983,349
+0.3%
0.00%0.0%
Q2 2022$8,902,000
-10.2%
980,362
+0.3%
0.00%0.0%
Q1 2022$9,918,000
-49.7%
977,197
-17.3%
0.00%0.0%
Q4 2021$19,716,000
-75.1%
1,182,036
-30.0%
0.00%
-83.3%
Q3 2021$79,123,000
-6.4%
1,688,150
+21.7%
0.01%
-14.3%
Q2 2021$84,532,000
-17.1%
1,386,688
-16.2%
0.01%
-22.2%
Q1 2021$101,983,000
+1.6%
1,655,564
+17.3%
0.01%0.0%
Q4 2020$100,356,000
+161.0%
1,411,271
+37.7%
0.01%
+125.0%
Q3 2020$38,455,000
-23.9%
1,024,953
-33.8%
0.00%
-33.3%
Q2 2020$50,510,000
+7.0%
1,548,896
-4.8%
0.01%
-14.3%
Q1 2020$47,191,000
-38.6%
1,627,252
-25.8%
0.01%
-12.5%
Q4 2019$76,855,000
+35.7%
2,192,700
-16.9%
0.01%
+14.3%
Q3 2019$56,619,000
-30.4%
2,637,138
-12.6%
0.01%
-30.0%
Q2 2019$81,395,0003,017,9860.01%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders